Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Xpress
The study found that frequent use of high-potency cannabis is associated with changes in genes related to mitochondrial and immune function, particularly affecting the CAVIN1 gene.
Internal Medicine October 21st 2024
Mayo Clinic
Kratom’s active compounds can produce both stimulant and sedative effects, depending on the dose, but its safety profile and efficacy remain poorly understood.
Gastroenterology October 14th 2024
British Medical Journal
A new network meta-analysis reveals that high-dose psilocybin may be as effective as escitalopram for treating depressive symptoms, with a standardized mean difference of 0.31 compared to placebo in antidepressant trials.
Psychiatry September 10th 2024
Psychiatrist.com
A 24-year prospective study involving 362 inpatients with borderline personality disorder (BPD) has found that while the prevalence of symptomatic disorders declines over time, the absence of substance use disorders is the strongest predictor of BPD recovery.
Psychiatry August 27th 2024
The New England Journal of Medicine
Purulent pericarditis, while rare, remains a potentially fatal complication that requires prompt recognition and management, particularly in patients with a history of intravenous drug use.
Cardiology August 5th 2024
Psychiatry Advisor
Cannabis use was associated with a more than 11 times greater risk for psychotic disorder among adolescents, compared to no cannabis use.
Psychiatry July 30th 2024